New York, NY -- (SBWIRE) -- 01/15/2013 -- Amarantus Biosciences Inc (OTCQB: AMBS) published a blog post on TheChairmansBlog.com. The company stated the corporate milestones to set the stage for growth in 2013, including - Publicly releasing ground-breaking efficacy data for the protein drug candidate MANF in a neurorestoration animal model of Parkinson’s disease, their lead therapeutic indication; - Acquiring 25 pieces of intellectual property from Power3 Medical Products, Inc. (“Power3”) related to the diagnosis of a number of neurodegenerative diseases and cancers. The transaction also included the buyout of their Parkinson’s disease license with Power3; and - Licensing a Phase 2-ready Alzheimer’s disease diagnostic blood test called LymPro to detect mild to moderate Alzheimer’s disease; a diagnostic category highly sought by Big Pharma.
Find out more on AMBS by getting the free full report here: http://www.monstertradingalerts.com/market-scan/?symbol=AMBS
Organovo Holdings, Inc. (PINKSHEETS: ONVO) has started the year with a strong bullish drive. The share price is currently trading around $3.57 and was up 9.85 percent for the last session. ONVO is working together with researchers at Autodesk, Inc., the leader in cloud-based design and engineering software, to create the first 3D design software for bioprinting.
Organovo Holdings Inc (ONVO), formerly Real Estate Restoration & Rental, Inc., is a development-stage company. In 2012 MIT’s Technology Review added Organovo Holdings, Inc in its list of most innovative companies of the year. On December 28, 2011, Real Estate Restoration and Rental, Inc.’s (RERR) entered into an Agreement and Plan of Merger, pursuant to which RERR merged with its, wholly owned subsidiary, Organovo (Merger Sub).
Find out more on ONVO by getting the free full report here: http://www.monstertradingalerts.com/market-scan/?symbol=ONVO
MonsterTradingAlerts.com issues momentum alerts on stocks that can provide gains to day traders. MonsterTradingAlerts.com provides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver gains of 100% - 200% or more. MonsterTradingAlerts.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals MonsterTradingAlerts.com is often in the know of several large investor awareness campaigns being deployed.
Timing is everything when trading Penny Stocks. Gain an Edge by joining the MonsterTradingAlerts.com newsletter and receiving alerts from a Pro-Active team of researchers. Trading Alerts believes traders should have a chance at successfully trading penny stocks and invites traders and investors to be part of the Free VIP membership.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.MonsterTradingAlerts.com
Disclosure: MonsterTradingAlerts.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit MonsterTradingAlerts.com website, for complete risks and disclosures.
Investor Alley, its employees, officers, directors, shareholders and affiliates, hold no positions in the above-mentioned stocks.
Alexander K. Neumann
Monster Trading Alerts